SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Stephen S. Johnston, Donna McMorrow, Amanda M. Farr, Paul Juneau, Sarika Ogale, Comparison of Healthcare Costs Between Rheumatoid Arthritis Patients Treated with Infused Biologics After Switching from Another Biologic, Drugs - Real World Outcomes, 2015, 2, 1, 99

    CrossRef

  2. 2
    Jos Hendrikx, Jaap Fransen, Wietske Kievit, Piet L. C. M. van Riel, Individual patient monitoring in daily clinical practice: a critical evaluation of minimal important change, Quality of Life Research, 2015, 24, 3, 607

    CrossRef

  3. 3
    Themistocles Dassopoulos, Dario Sorrentino, Infliximab vs Adalimumab for Crohn’s Disease: Perhaps too Early to Call It a Tie, Clinical Gastroenterology and Hepatology, 2014, 12, 5, 818

    CrossRef

  4. 4
    Shuji Ohta, Tomomi Tsuru, Kimio Terao, Seiji Mogi, Midori Suzaki, Eisuke Shono, Yoshimasa Ishida, Eriko Tarumi, Masato Imai, Mechanism-based approach using a biomarker response to evaluate tocilizumab subcutaneous injection in patients with rheumatoid arthritis with an inadequate response to synthetic DMARDs (MATSURI study), The Journal of Clinical Pharmacology, 2014, 54, 1
  5. 5
    Atsushi Ogata, Kazuhide Tanimura, Toyohiko Sugimoto, Hiroshi Inoue, Yukitomo Urata, Tsukasa Matsubara, Masakazu Kondo, Yukitaka Ueki, Mitsuhiro Iwahashi, Shigeto Tohma, Shuji Ohta, Yukihiko Saeki, Toshio Tanaka, Phase III Study of the Efficacy and Safety of Subcutaneous Versus Intravenous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis, Arthritis Care & Research, 2014, 66, 3
  6. 6
    S. T. de Vries, J. Voorham, F. M. Haaijer-Ruskamp, P. Denig, Potential Overtreatment and Undertreatment of Diabetes in Different Patient Age Groups in Primary Care After the Introduction of Performance Measures, Diabetes Care, 2014, 37, 5, 1312

    CrossRef

  7. 7
    Alan Kivitz, Ewa Olech, Michael Borofsky, Beatriz M. Zazueta, Federico Navarro-Sarabia, Sebastião C. Radominski, Joan T. Merrill, Lucy Rowell, Clare Nasmyth-Miller, Min Bao, Stephen Wright, Janet E. Pope, Subcutaneous Tocilizumab Versus Placebo in Combination With Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis, Arthritis Care & Research, 2014, 66, 11
  8. 8
    R. W. Stidham, T. C. H. Lee, P. D. R. Higgins, A. R. Deshpande, D. A. Sussman, A. G. Singal, B. J. Elmunzer, S. D. Saini, S. Vijan, A. K. Waljee, Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn's disease, Alimentary Pharmacology & Therapeutics, 2014, 39, 12
  9. 9
    R. W. Stidham, T. C. H. Lee, P. D. R. Higgins, A. R. Deshpande, D. A. Sussman, A. G. Singal, B. J. Elmunzer, S. D. Saini, S. Vijan, A. K. Waljee, Systematic review with network meta-analysis: the efficacy of anti-tumour necrosis factor-alpha agents for the treatment of ulcerative colitis, Alimentary Pharmacology & Therapeutics, 2014, 39, 7
  10. 10
    Reginald Villacorta, Joel W. Hay, Andrew Messali, Cost Effectiveness of Moderate to Severe Psoriasis Therapy with Etanercept and Ustekinumab in the United States, PharmacoEconomics, 2013, 31, 9, 823

    CrossRef

  11. 11
    Olivier Muis Pistor, Bruno Fantino, Françoise Piot-Fantino, Christophe Garret, Gérard Trape, Jacques Tebib, Diagnostic et prise en charge thérapeutique de la polyarthrite rhumatoïde en Rhône-Alpes : une enquête « vraie vie » en 2010, Revue du Rhumatisme, 2013, 80, 2, 130

    CrossRef

  12. 12
    Paul Arkell, Sarah Ryan, Ann Brownfield, Anthony Cadwgan, Jon Packham, Patient experiences, attitudes and expectations towards receiving information about anti-TNF medication – “It could give me two heads and I’d still try it!”, BMC Musculoskeletal Disorders, 2013, 14, 1, 165

    CrossRef

  13. 13
    Li-Hao Chu, Cecilia Portugal, Aniket A. Kawatkar, William Stohl, Michael B. Nichol, Racial/ethnic differences in the use of biologic disease-modifying antirheumatic drugs among California Medicaid rheumatoid arthritis patients, Arthritis Care & Research, 2013, 65, 2
  14. 14
    Anthony Buisson, Anne-Laure Seigne, Marie-Caroline DʼHuart, Marc-André Bigard, Laurent Peyrin-Biroulet, The Extra Burden of Infliximab Infusions in Inflammatory Bowel Disease, Inflammatory Bowel Diseases, 2013, 19, 11, 2464

    CrossRef

  15. 15
    U. Müller-Ladner, R. M. Flipo, P. Vincendon, Y. Brault, D. Kielar, Comparison of patient satisfaction with two different etanercept delivery systems, Zeitschrift für Rheumatologie, 2012, 71, 10, 890

    CrossRef

  16. 16
    Justine M. Naylor, Rajat Mittal, Katherine Carroll, Ian A. Harris, Introductory insights into patient preferences for outpatient rehabilitation after knee replacement: implications for practice and future research, Journal of Evaluation in Clinical Practice, 2012, 18, 3
  17. 17
    Heather F. Burnett, Dean A. Regier, Brian M. Feldman, Fiona A. Miller, Wendy J. Ungar, Parents' preferences for drug treatments in juvenile idiopathic arthritis: A discrete choice experiment, Arthritis Care & Research, 2012, 64, 9
  18. 18
    Adriana Del Giglio, Beatrice Abdala, Carolina Ogawa, Daniel Amado, Diego Carter, Fernanda Gomieiro, Fernanda Salama, Marina Shiroma, Auro del Giglio, Qualidade da informação da internet disponível para pacientes em páginas em português, Revista da Associação Médica Brasileira (English Edition), 2012, 58, 6, 645

    CrossRef

  19. 19
    Adriana Del Giglio, Beatrice Abdala, Carolina Ogawa, Daniel Amado, Diego Carter, Fernanda Gomieiro, Fernanda Salama, Marina Shiroma, Auro del Giglio, Qualidade da informação da internet disponível para pacientes em páginas em português, Revista da Associação Médica Brasileira, 2012, 58, 6, 645

    CrossRef

  20. 20
    Adriana Del Giglio, Beatrice Abdala, Carolina Ogawa, Daniel Amado, Diego Carter, Fernanda Gomieiro, Fernanda Salama, Marina Shiroma, Auro del Giglio, Qualidade da informação da internet disponível para pacientes em páginas em português, Revista da Associação Médica Brasileira, 2012, 58, 6, 645

    CrossRef

  21. 21
    Stephan R. Vavricka, Nicoletta Bentele, Michael Scharl, Gerhard Rogler, Jonas Zeitz, Pascal Frei, Alex Straumann, Janek Binek, Alain M. Schoepfer, Michael Fried, Systematic assessment of factors influencing preferences of crohn's disease patients in selecting an anti-tumor necrosis factor agent (CHOOSE TNF TRIAL), Inflammatory Bowel Diseases, 2012, 18, 8
  22. You have free access to this content22
    S. Danese, J.-F. Colombel, W. Reinisch, P. J. Rutgeerts, Review article: infliximab for Crohn’s disease treatment – shifting therapeutic strategies after 10 years of clinical experience, Alimentary Pharmacology & Therapeutics, 2011, 33, 8
  23. 23
    L. T. C. van Hulst, W. Kievit, R. van Bommel, P. L. C. M. van Riel, L. Fraenkel, Rheumatoid arthritis patients and rheumatologists approach the decision to escalate care differently: Results of a maximum difference scaling experiment, Arthritis Care & Research, 2011, 63, 10
  24. 24
    Susan M. Oliver, The Role of the Clinical Nurse Specialist in the Assessment and Management of Biologic Therapies, Musculoskeletal Care, 2011, 9, 1
  25. 25
    L. T. C. van Hulst, M. C. W. Creemers, J. Fransen, L. C. Li, R. Grol, M. E. J. L. Hulscher, P. L. C. M. van Riel, How to improve DAS28 use in daily clinical practice?--a pilot study of a nurse-led intervention, Rheumatology, 2010, 49, 4, 741

    CrossRef

  26. 26
    Miguel Cordero-Coma, Manuel Franco Benito, Carlos Lobato Fuertes, Sara Calleja Antolín, José M. García Ruíz, Adalimumab for Mooren's Ulcer, Ophthalmology, 2009, 116, 8, 1589

    CrossRef

  27. 27
    Miltiadis Tsilimbaris, Vasilios F. Diakonis, Irini Naoumidi, Spyridon Charisis, Iraklis Kritikos, George Chatzithanasis, Thekla Papadaki, Sotiris Plainis, Evaluation of potential retinal toxicity of adalimumab (Humira), Graefe's Archive for Clinical and Experimental Ophthalmology, 2009, 247, 8, 1119

    CrossRef

  28. 28
    Tessa Sanderson, Michael Calnan, Marianne Morris, Pam Richards, Sarah Hewlett, The impact of patient-perceived restricted access to anti-TNF therapy for rheumatoid arthritis: a qualitative study, Musculoskeletal Care, 2009, 7, 3